A detailed history of Principal Financial Group Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 15,275 shares of IDYA stock, worth $508,504. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,275
Previous 14,627 4.43%
Holding current value
$508,504
Previous $520,000 28.85%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$34.2 - $47.13 $22,161 - $30,540
648 Added 4.43%
15,275 $670,000
Q4 2023

Feb 07, 2024

BUY
$24.59 - $35.83 $5,213 - $7,595
212 Added 1.47%
14,627 $520,000
Q3 2023

Nov 02, 2023

BUY
$21.07 - $29.77 $14,243 - $20,124
676 Added 4.92%
14,415 $388,000
Q2 2023

Aug 07, 2023

BUY
$13.33 - $25.53 $20,954 - $40,133
1,572 Added 12.92%
13,739 $322,000
Q1 2023

May 09, 2023

BUY
$13.49 - $18.72 $23,324 - $32,366
1,729 Added 16.56%
12,167 $167,000
Q4 2022

Feb 09, 2023

BUY
$14.47 - $18.17 $151,037 - $189,658
10,438 New
10,438 $189,000
Q2 2022

Aug 10, 2022

SELL
$8.28 - $13.88 $157,295 - $263,678
-18,997 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$11.18 - $24.02 $84,979 - $182,576
-7,601 Reduced 28.58%
18,997 $213,000
Q4 2021

Feb 09, 2022

BUY
$20.95 - $26.88 $557,228 - $714,954
26,598 New
26,598 $629,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.6B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.